Informations techniques
Exploitant
Laboratoires PROSTRAKAN PHARMA
Présentation
DROLEPTAN 2,5 mg/ 1ml, solution injectable (IV) B/10 - CIP 561 122-8
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
RY5Wzu4TMAAT0ZDb